Table 4—

Nonduplicated pooled prevalence estimates for chronic obstructive pulmonary disease by category

EstimatesCasesTotal populationPrevalence %Pooled prevalence %p-value#
Overall3711126141236468.9 (2.1–26.4)7.6 (6.0–9.5)
Age
 <40 yrs91074253622.7 (0.8–10.6)3.1 (1.8–5.0)<0.0001
 ≥40 yrs344933460959.7 (1.8–29.7)9.9 (8.2–11.8)
 40–64 yrs232793309427.6 (1.8–28.7)8.2 (6.5–10.3)
 ≥65 yrs1121401515315.0 (4.8–29.7)14.2 (11.0–18.0)
Smoking status
 Smoker1731332412215.2 (5.1–39.7)15.4 (11.2–20.7)<0.0001
 Ex-smoker1612401452112.7 (2.8–27.7)10.7 (8.1–14.0)
 Never-smoker161235325423.9 (0.7–14.6)4.3 (3.2–5.7)
Sex
 Male271648032729311.0 (2.5–28.0)9.8 (8.0–12.1)0.0002
 Female27120243563985.0 (1.8–25.2)5.6 (4.4–7.0)
WHO region
 Africa0000.7768
 Americas32666275994.5 (3.2–14.0)4.6 (2.8–7.6)
 Eastern Mediterranean000
 Europe2810477340154558.3 (2.1–26.4)7.4 (5.9–9.3)
 South-East Asia2+747604412.5 (7.1–17.9)11.4 (4.4–26.4)
 Western Pacific4§30757454810.6 (3.0–18.2)9.0 (3.0–24.1)
Study setting
 Urban1240964415310.3 (3.6–26.4)10.2 (7.4–13.9)0.0438
 Mixed2110557140759654.9 (2.3–17.8)6.1 (4.9–7.7)
 Rural443734828.4 (2.1–18.3)8.0 (3.9–15.8)
Study quality
 Good15235395836586.8 (3.2–18.3)6.8 (5.2–8.9)0.6958
 Average1364341249607.1 (2.1–14.6)6.7 (4.5–9.8)
 Poor980131341498210.5 (2.3–26.4)9.9 (4.2–21.6)
  • Data are presented as n. Prevalences are presented as median (range) and pooled prevalences as pooled prevalence estimate (95% confidence interval). WHO: World Health Organization. #: heterogeneity between strata calculated using Q statistic (e.g. males versus females); : Canada and USA; +: Thailand and India; §: China, Japan and South Korea. Heterogeneity within each stratum, as calculated by the Q statistic, was significant for all strata with more than one estimate (p<0.0001).